Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China flag China · Delayed Price · Currency is CNY
7.10
-0.10 (-1.39%)
Sep 2, 2026, 3:04 PM CST

SHE:002566 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
372952.0994.7383.196.02
Depreciation & Amortization
41.2642.747.0848.9344.2743.09
Other Amortization
0.690.680.631.530.921.18
Loss (Gain) From Sale of Assets
-0.12-0.4-0.29-0.78--
Asset Writedown & Restructuring Costs
-5.30.30.270.240.270.28
Loss (Gain) From Sale of Investments
-10.02-9.53-11.98-4.02-2.62-0.25
Provision & Write-off of Bad Debts
2.132.13-0.23-1.27-0.46
Other Operating Activities
14.8915.614.2610.8819.9922.41
Change in Accounts Receivable
-7.18-29.655.2175.22-17.02-31.92
Change in Inventory
38.4443.03-11.33-12.65-4.9917.85
Change in Accounts Payable
-3.368.01-37.26-7.0918.5464.21
Operating Cash Flow
105.4698.7458.94209.13145.86215.1
Operating Cash Flow Growth
118.02%67.51%-71.81%43.38%-32.19%5.69%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-6.49-13.64-15.94-35.77-41.36-107.07
Sale of Property, Plant & Equipment
-0.320.280.450.74-0
Investment in Securities
-80.04-51.76-365-4040-100
Other Investing Activities
12.211.715.291.643.13-
Investing Cash Flow
-74.65-53.42-375.21-73.391.77-207.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-20--430397.45
Long-Term Debt Issued
-333600520--
Total Debt Issued
335353600520430397.45
Short-Term Debt Repaid
-----400-415
Long-Term Debt Repaid
--360.64-638.35-484.84-3.06-5.75
Total Debt Repaid
-340.74-360.64-638.35-484.84-403.06-420.75
Net Debt Issued (Repaid)
-5.74-7.64-38.3535.1626.94-23.3
Common Dividends Paid
-38.76-45.61-61.64-29.86--23.32
Other Financing Activities
-2.13--3.43-50.99-28.72
Financing Cash Flow
-46.64-53.25-99.998.73-24.06-75.34

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
00-0---
Net Cash Flow
-15.82-7.93-416.25144.47123.57-67.3

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
98.9885.143173.36104.49108.04
Free Cash Flow Growth
167.53%97.89%-75.19%65.91%-3.28%-15.32%
Free Cash Flow Margin
15.21%13.29%6.43%20.31%12.59%12.31%
Free Cash Flow Per Share
0.300.260.130.520.320.33
Levered Free Cash Flow
93.454.519.6594.7277.275.5
Unlevered Free Cash Flow
101.2962.418.3103.2686.0413.85

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
93.6589.7796.65113.44100.2698.63
Change in Working Capital
24.9318.26-42.8757.63-1.3452.82